FundingWatcher
Home / Startups / By venture fund / Invus portfolio companies

Invus portfolio companies

Updated 16 Nov 2026

http://www.invus.com

Invus portfolio companies
One-time CSV
  • 25 funded companies, 21 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-invus.csv25 rows × 18 columns
CompanyCityLast roundAmountDate
Lycia TherapeuticsSouth San FranciscoSeries D$75.0M2026-06-25
Triveni BioWatertownSeries C$65.0M2026-06-17
Convergent TherapeuticsCambridgeSeries A$40.0M2024-09-24
SepternaSan FranciscoSeries B$150.0M2023-07-11
NextPoint TherapeuticsCambridgeSeries B$42.5M2024-02-14
JumbotailBangaloreSeries D$120.0M2025-06-30
Lyndra TherapeuticsWatertownSeries E$101.0M2023-12-21
Autobahn TherapeuticsSan DiegoSeries C$100.0M2024-07-24

8 rows of the CSV in 5 of its 18 columns.

25
Startups
$5.9B
Total raised
2
Funded in the last 12 months
$140.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

13 of 25
13 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco, United States Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
Jumbotail Jumbotail operates a B2B e-commerce marketplace for food and grocery distribution. Commerce Bangalore, India Series D $120.0M 2025-06-30 $298.6M Nexus Venture Partners, Kalaari Capital, InnoVen Capital +2 101 to 250 2015
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel, Switzerland Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Convergent Therapeutics Convergent Therapeutics develops radiopharmaceutical therapies for prostate cancer. Health care Cambridge, United States Series A $40.0M 2024-09-24 $130.0M RA Capital Management, OrbiMed, Invus 1 to 10 2021
Autobahn Therapeutics Autobahn Therapeutics develops restorative treatments for neuropsychiatric and neuroimmunologic disorders. Biotech San Diego, United States Series C $100.0M 2024-07-24 $208.7M Insight Partners, Invus, Bristol-Myers Squibb +2 11 to 50 2017
Endeavor BioMedicines Endeavor BioMedicines develops treatments that target the underlying causes of pulmonary fibrosis. Biotech Solana Beach, United States Series C $132.5M 2024-04-24 $295.5M Fidelity, Invus, T. Rowe Price +2 11 to 50 2018
NextPoint Therapeutics NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. Biotech Cambridge, United States Series B $42.5M 2024-02-14 $122.5M Invus, Leaps by Bayer, Catalio Capital Management +2 51 to 100 2020
Lyndra Therapeutics Lyndra Therapeutics creates oral dosage forms that release drugs over the long term. Biotech Watertown, United States Series E $101.0M 2023-12-21 $284.6M Polaris Partners, Bill & Melinda Gates Foundation, Invus 51 to 100 2015
Booster Booster runs fleet management and delivers renewable fuels, gasoline, diesel, and biodiesel. Energy Seattle, United States Series D $125.0M 2022-05-25 $213.6M RRE Ventures, Maveron, Invus +1 251 to 500 2014
Marlette Funding Marlette Funding is a financial technology company that serves customers with lending products. Fintech Wilmington, United States Series E $225.0M 2022-03-10 $2.1B Invus, Healthcare of Ontario Pension Plan (HOOPP) 501 to 1,000 2013
Future Finance Future Finance is a non-government lender that offers student loans. Education Dublin, Ireland Series D $25.8M 2019-07-09 Goldman Sachs, QED Investors, Invus +2 101 to 250 2014
MarkaVIP MarkaVIP is an invitation-only online shopping community serving the Middle Eastern market. Commerce Amman, Jordan Series B $10.0M 2012-04-25 Invus, Hummingbird Ventures, Prime Ventures +1 501 to 1,000 2010

Table 1. Invus portfolio companies: the 13 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 25.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco, United States Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
2 Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019

Table 2. Invus portfolio companies: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 OrbiMed Private equity firm New York, United States 5 20% 1 Triveni Bio
2 Polaris Partners Private equity firm Boston, United States 4 16% 1 Triveni Bio
3 Blue Owl Private equity firm New York, United States 3 12% 1 Lycia Therapeutics
4 RA Capital Management Startup incubator Boston, United States 3 12%
5 Fidelity Investment bank Boston, United States 3 12%
6 Alexandria Venture Investments Venture capital firm Pasadena, United States 2 8% 2 Lycia Therapeutics, Triveni Bio
7 Catalio Capital Management Venture capital firm New York, United States 2 8%
8 Insight Partners Private equity firm New York, United States 2 8%
9 Goldman Sachs Investment bank New York, United States 2 8%
10 Franklin Templeton Private equity firm San Mateo, United States 1 4% 1 Lycia Therapeutics
11 Cormorant Asset Management Hedge fund Boston, United States 1 4% 1 Triveni Bio
12 Biotechnology Value Fund Venture capital firm San Francisco, United States 1 4%
13 Samsara BioCapital Private equity firm Palo Alto, United States 1 4%
14 Arkin Capital Hedge fund Herzliya, Israel 1 4%
15 MPM Capital Private equity firm Boston, United States 1 4%

Table 3. Invus portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 15 60% $3.3B
Biotech 12 48% $3.0B
Software 6 24% $297.0M
Commerce 4 16% $298.6M
Fintech 2 8% $2.1B
Education 2 8%
Hardware 2 8%
Artificial intelligence 1 4% $47.0M
Energy 1 4% $213.6M

Table 4. Invus portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 1 4% $1.2M
Series A 6 24% $40.0M
Series B 6 24% $132.0M
Series C 6 24% $100.0M
Series D+ 6 24% $120.0M

Table 5. Invus portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 17 68%
Switzerland 2 8%
France 2 8%
India 1 4%
Ireland 1 4%
Jordan 1 4%
Canada 1 4%

Table 6. Invus portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Cambridge 4 16%
Watertown 2 8%
San Diego 2 8%
Boston 2 8%
Paris 2 8%
South San Francisco 1 4%
San Francisco 1 4%
Bangalore 1 4%
Allschwil 1 4%
Basel 1 4%
Solana Beach 1 4%
Wilmington 1 4%

Table 7. Invus portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
June 2026 2 100% $140.0M

Table 8. Invus portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 2 8% $140.0M
2025 1 4% $120.0M
2024 10 40% $950.1M
2023 4 16% $363.0M
2022 2 8% $350.0M
2021 1 4% $1.2M

Table 9. Invus portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 8%
2020 to 2022 7 28%
2015 to 2019 10 40%
2010 to 2014 4 16%
Before 2010 2 8%

Table 10. Invus portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 2 8%
11 to 50 8 33%
51 to 100 7 29%
101 to 250 3 12%
251 to 500 2 8%
501 to 1,000 2 8%

Table 11. Invus portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many Invus portfolio companies are on the list?
25, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 25 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Invus portfolio companies: 25 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 25 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/invus/